Abstract
Genome-wide losses of DNA methylation have been regarded as a common epigenetic event in malignancies and may play crucial roles in carcinogenesis. Limited information is available on the global methylation status in normal tissues and other cancer types beyond colonic carcinoma. Here we applied the combined bisulfite restriction analysis PCR to evaluate the methylation status of LINE-1 repetitive sequences in genomic DNA derived from microdissected samples from several human normal and neoplastic tissues. We found that methylation of LINE-1 in leukocytes was independent of age and gender. In contrast, normal tissues from different organs showed tissue-specific levels of methylated LINE-1. Globally, most carcinomas including breast, colon, lung, head and neck, bladder, esophagus, liver, prostate, and stomach, revealed a greater percentage of hypomethylation than their normal tissue counterparts. Furthermore, DNA derived from sera of patients with carcinoma displayed more LINE-1 hypomethylation than those of noncarcinoma individuals. Finally, in a colonic carcinogenesis model, we detected significantly greater hypomethylation in carcinoma than those of dysplastic polyp and histological normal colonic epithelium. Thus, the methylation status is a unique feature of a specific tissue type and the global hypomethylation is a common epigenetic process in cancer, which may progressively evolve during multistage carcinogenesis.
Similar content being viewed by others
References
Anker P and Stroun M . (2000). Medicina (B Aires), 60, 699–702.
Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, Wu Y, He X, Powe NR and Feinberg AP . (2003). Science, 299, 1753–1755.
Dunn BK . (2003). Ann. N. Y. Acad. Sci., 983, 28–42.
Feinberg AP and Tycko B . (2004). Nat. Rev. Cancer, 4, 143–153.
Feinberg AP and Vogelstein B . (1983). Nature, 301, 89–92.
Florl AR, Lower R, Schmitz-Drager BJ and Schulz WA . (1999). Br. J. Cancer, 80, 1312–1321.
Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H and Jaenisch R . (2003). Science, 300, 489–492.
Goelz SE, Vogelstein B, Hamilton SR and Feinberg AP . (1985). Science, 228, 187–190.
Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB . (1996). Proc. Natl. Acad. Sci. USA, 93, 9821–9826.
Jurgens B, Schmitz-Drager BJ and Schulz WA . (1996). Cancer Res., 56, 5698–5703.
Kaneda A, Tsukamoto T, Takamura-Enya T, Watanabe N, Kaminishi M, Sugimura T, Tatematsu M and Ushijima T . (2004). Cancer Sci., 95, 58–64.
Kazazian Jr HH and Moran JV . (1998). Nat. Genet., 19, 19–24.
Lyon MF . (1994). Eur. J. Hum. Genet., 2, 255–261.
Mutirangura A, Charuruks N, Shuangshoti S, Sakdikul S, Chatsantikul R, Pornthanakasem W, Sriuranpong V, Supiyaphun P and Voravud N . (1999). Int. J. Cancer, 83, 210–214.
Mutirangura A, Pornthanakasem W, Theamboonlers A, Sriuranpong V, Lertsanguansinchi P, Yenrudi S, Voravud N, Supiyaphun P and Poovorawan Y . (1998). Clin. Cancer Res., 4, 665–669.
Reik W, Dean W and Walter J . (2001). Science, 293, 1089–1093.
Santourlidis S, Florl A, Ackermann R, Wirtz HC and Schulz WA . (1999). Prostate, 39, 166–174.
Schramke V and Allshire R . (2003). Science, 301, 1069–1074.
Sugimura T and Ushijima T . (2000). Mutat Res., 462, 235–246.
Suter CM, Martin DI and Ward RL . (2004). Int. J. Colorectal Dis., 19, 95–101.
Takai D, Yagi Y, Habib N, Sugimura T and Ushijima T . (2000). Jpn. J. Clin. Oncol., 30, 306–309.
Xiong Z and Laird PW . (1997). Nucleic Acids Res., 25, 2532–2534.
Yang AS, Estecio MR, Garcia-Manero G, Kantarjian HM and Issa JP . (2003). Science, 302, 1153 author reply 1153.
Acknowledgements
We thank all the staff of the Department of Pathology for assistance in providing the tissue samples, and Professor Emeritus Dr Samruay Shuangshoti, Chulalongkorn University, and Dr Richard Paul, Institut Pastuer, for critically reviewing the manuscript. This work is supported by the Thailand Research Funds, National Center for Genetic Engineering and Biotechnology, and the Molecular Biology and Genetics of Cancer Development Research Unit, Chulalongkorn University.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chalitchagorn, K., Shuangshoti, S., Hourpai, N. et al. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23, 8841–8846 (2004). https://doi.org/10.1038/sj.onc.1208137
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208137
- Springer Nature Limited
Keywords
This article is cited by
-
CRISPR-based DNA methylation editing of NNT rescues the cisplatin resistance of lung cancer cells by reducing autophagy
Archives of Toxicology (2023)
-
Hybridization-based CpG methylation level detection using methyl-CpG-binding domain–fused luciferase
Analytical and Bioanalytical Chemistry (2023)
-
Global DNA hypomethylation of colorectal tumours detected in tissue and liquid biopsies may be related to decreased methyl-donor content
BMC Cancer (2022)
-
Quantification of global DNA methylation level using 5-methylcytosine dioxygenase
Analytical and Bioanalytical Chemistry (2020)
-
A systematic literature review assessing if genetic biomarkers are predictors for platinum-based chemotherapy response in ovarian cancer patients
European Journal of Clinical Pharmacology (2020)